Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1077

1.

Enhancement of nuclear factor-kappa B acetylation by coactivator p300 and HIV-1 Tat proteins.

Furia B, Deng L, Wu K, Baylor S, Kehn K, Li H, Donnelly R, Coleman T, Kashanchi F.

J Biol Chem. 2002 Feb 15;277(7):4973-80. Epub 2001 Dec 5.

2.

Enhancement of the p300 HAT activity by HIV-1 Tat on chromatin DNA.

Deng L, Wang D, de la Fuente C, Wang L, Li H, Lee CG, Donnelly R, Wade JD, Lambert P, Kashanchi F.

Virology. 2001 Oct 25;289(2):312-26.

3.

Acetylation of HIV-1 Tat by CBP/P300 increases transcription of integrated HIV-1 genome and enhances binding to core histones.

Deng L, de la Fuente C, Fu P, Wang L, Donnelly R, Wade JD, Lambert P, Li H, Lee CG, Kashanchi F.

Virology. 2000 Nov 25;277(2):278-95.

4.

The histone acetyltransferase, hGCN5, interacts with and acetylates the HIV transactivator, Tat.

Col E, Caron C, Seigneurin-Berny D, Gracia J, Favier A, Khochbin S.

J Biol Chem. 2001 Jul 27;276(30):28179-84. Epub 2001 May 30.

5.

Acetylation of the HIV-1 Tat protein by p300 is important for its transcriptional activity.

Ott M, Schnölzer M, Garnica J, Fischle W, Emiliani S, Rackwitz HR, Verdin E.

Curr Biol. 1999 Dec 16-30;9(24):1489-92.

6.

Human immunodeficiency virus type-1 Tat/co-activator acetyltransferase interactions inhibit p53Lys-320 acetylation and p53-responsive transcription.

Harrod R, Nacsa J, Van Lint C, Hansen J, Karpova T, McNally J, Franchini G.

J Biol Chem. 2003 Apr 4;278(14):12310-8. Epub 2002 Dec 24.

7.

HIV-1 Tat interactions with p300 and PCAF transcriptional coactivators inhibit histone acetylation and neurotrophin signaling through CREB.

Wong K, Sharma A, Awasthi S, Matlock EF, Rogers L, Van Lint C, Skiest DJ, Burns DK, Harrod R.

J Biol Chem. 2005 Mar 11;280(10):9390-9. Epub 2004 Dec 15.

8.

PIAS3 suppresses NF-kappaB-mediated transcription by interacting with the p65/RelA subunit.

Jang HD, Yoon K, Shin YJ, Kim J, Lee SY.

J Biol Chem. 2004 Jun 4;279(23):24873-80. Epub 2004 Mar 26.

9.

Centrosomal P4.1-associated protein is a new member of transcriptional coactivators for nuclear factor-kappaB.

Koyanagi M, Hijikata M, Watashi K, Masui O, Shimotohno K.

J Biol Chem. 2005 Apr 1;280(13):12430-7. Epub 2005 Jan 31.

10.

Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription.

Balasubramanyam K, Varier RA, Altaf M, Swaminathan V, Siddappa NB, Ranga U, Kundu TK.

J Biol Chem. 2004 Dec 3;279(49):51163-71. Epub 2004 Sep 20.

11.

HIV-1 tat transcriptional activity is regulated by acetylation.

Kiernan RE, Vanhulle C, Schiltz L, Adam E, Xiao H, Maudoux F, Calomme C, Burny A, Nakatani Y, Jeang KT, Benkirane M, Van Lint C.

EMBO J. 1999 Nov 1;18(21):6106-18.

12.
13.

Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.

Scala G, Quinto I, Ruocco MR, Mallardo M, Ambrosino C, Squitieri B, Tassone P, Venuta S.

J Virol. 1993 May;67(5):2853-61.

14.
15.

Post-activation turn-off of NF-kappa B-dependent transcription is regulated by acetylation of p65.

Kiernan R, Brès V, Ng RW, Coudart MP, El Messaoudi S, Sardet C, Jin DY, Emiliani S, Benkirane M.

J Biol Chem. 2003 Jan 24;278(4):2758-66. Epub 2002 Nov 4.

16.

Regulation of HIV-1 long terminal repeats by interaction of C/EBP(NF-IL6) and NF-kappaB/Rel transcription factors.

Ruocco MR, Chen X, Ambrosino C, Dragonetti E, Liu W, Mallardo M, De Falco G, Palmieri C, Franzoso G, Quinto I, Venuta S, Scala G.

J Biol Chem. 1996 Sep 13;271(37):22479-86.

17.

HIV-1 regulatory protein tat induces RNA binding proteins in central nervous system cells that associate with the viral trans-acting-response regulatory motif.

Kundu M, Ansari SA, Chepenik LG, Pomerantz RJ, Khalili K, Rappaport J, Amini S.

J Hum Virol. 1999 Mar-Apr;2(2):72-80.

PMID:
10225209
18.

The hepatitis B virus X protein induces HIV-1 replication and transcription in synergy with T-cell activation signals: functional roles of NF-kappaB/NF-AT and SP1-binding sites in the HIV-1 long terminal repeat promoter.

Gómez-Gonzalo M, Carretero M, Rullas J, Lara-Pezzi E, Aramburu J, Berkhout B, Alcamí J, López-Cabrera M.

J Biol Chem. 2001 Sep 21;276(38):35435-43. Epub 2001 Jul 16.

20.

Artificial zinc finger fusions targeting Sp1-binding sites and the trans-activator-responsive element potently repress transcription and replication of HIV-1.

Kim YS, Kim JM, Jung DL, Kang JE, Lee S, Kim JS, Seol W, Shin HC, Kwon HS, Van Lint C, Hernandez N, Hur MW.

J Biol Chem. 2005 Jun 3;280(22):21545-52. Epub 2005 Mar 2.

Supplemental Content

Support Center